-
Mashup Score: 9
Data presented support broad potential therapeutic applications of MRT-6160 in a variety of autoimmune and inflammatory disorders driven by underlying dysregulation of T- and B-cells, including rheumatoid arthritis Investigational New Drug filing for MRT-6160 expected in 1H 2024 Data will be
Source: ir.monterosatx.comCategories: General Medicine News, Hem/OncsTweet
Check out poster #82 from @MonteRosaTx at #ACR23 on VAV1 molecular glue degrader (#MGD) in collagen-induced arthritis autoimmune disease model #ontonewheights https://t.co/QwGPHbEryc